The relationship of thyroid hormone status with myocardial function in stress cardiomyopathy

European Journal of Endocrinology

Volumn 160, Issue 5, 2009, Pages 799-806

  Lee, Seong Jin ^a,b   Kang, Jun Goo ^a   Ryu, Ohk Kyun ^a   Kim, Chul Sik ^a   Ihm, Sung Hee ^a   Gi Choi, Moon ^a   Yoo, Hyung Joon ^a   Hong, Kyung Soon ^a  

^a Hallym University   (South Korea)

^b Hallym University Sacred Heart Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; C REACTIVE PROTEIN; CATECHOLAMINE; CREATINE KINASE MB; DOPAMINE; HYDROCORTISONE; LIOTHYRONINE; NATRIURETIC PEPTIDE RECEPTOR B; NORADRENALIN; THYROID HORMONE; THYROID PEROXIDASE ANTIBODY; THYROTROPIN; TROPONIN I;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EUTHYROID SICK SYNDROME; FEMALE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE CONTRACTILITY; HUMAN; HYDROCORTISONE BLOOD LEVEL; LIOTHYRONINE BLOOD LEVEL; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; TAKOTSUBO CARDIOMYOPATHY; THYROTROPIN BLOOD LEVEL; AGED; BLOOD; BLOOD PRESSURE; CASE CONTROL STUDY; CONVALESCENCE; HEART; HEART LEFT VENTRICLE FUNCTION; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; POSTTRAUMATIC STRESS DISORDER; PREVALENCE;

AGED; BLOOD PRESSURE; CASE-CONTROL STUDIES; EUTHYROID SICK SYNDROMES; FEMALE; HEART; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RECOVERY OF FUNCTION; STRESS DISORDERS, TRAUMATIC; TAKOTSUBO CARDIOMYOPATHY; THYROID HORMONES; THYROTROPIN; VENTRICULAR FUNCTION, LEFT;

EID: 65549100010     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-08-0808     Document Type: Article

References (53)

1. Klein I & Ojamaa K. Thyroid hormone and cardiovascular system. New England Journal of Medicine 2001 344 501-509.
2. Danzi S & Klein I. Thyroid hormone-regulated cardiac gene expression and cardiovascular disease. Thyroid 2002 12 467-472.
3. Dillmann WH. Cellular action of thyroid hormone on the heart. Thyroid 2002 12 447-452.
4. Klein I. Thyroid hormone and contractility. American Journal of Cardiology 2003 91 1331-1332.
5. Klein I & Ojamaa K. Thyroid hormone: targeting the heart. Endocrinology 2001 142 11-12.
6. Sabatino L, Colantuoni A & Iervasi G. Is the vascular system a main target for thyroid hormones?, From molecular and biochemical findings to clinical perspectives Current Vascular Pharmacology 2005 3 133-145.
7. Kahaly GJ & Dillmann WH. Thyroid hormone action in the heart. Endocrine Reviews 2005 26 704-728.
8. Pantos C, Malliopoulou V, Varonos DD & Cokkinos DV. Thyroid hormone and phenotypes of cardioprotection. Basic Research in Cardiology 2004 99 101-120.
9. Klein I. Thyroid hormone and the cardiovascular system. American Journal of Medicine 1990 88 631-637.
10. Polikar R, Burger AG, Scherrer U & Nicod P. The thyroid and the heart. Circulation 1993 87 1435-1441.
11. Biondi B, Palmieri EA, Lombardi G & Fazio S. Subclinical hypothyroidism and cardiac function. Thyroid 2002 12 505-510.
12. Pantos C, Malliopoulou V, Mourouzis I, Sfakianoudis K, Tzeis S, Doumba P, Xinaris C, Cokkinos AD, Carageorgiou H, Varonos DD & Cokkinos DV. Prophylthiouracil induced hypothyroidism is associated with increased tolerance of the isolated rat heart to ischemia-reperfusion. Journal of Endocrinology 2003 178 427-435.
13. Kozdag G, Ural D, Vural A, Agacdiken A, Kahraman G, Sahin T, Ural E & Komsuoglu B. Relation between free triiodothyronine/free thyroxine ratio, echocardiographic parameters and mortality in dilated cardiomyopathy. European Journal of Heart Failure 2005 7 113-118.
14. Brenta G, Mutti LA, Schnitman M, Fretes O, Perrone A & Matute ML. Assessment of left ventricular diastolic function by radionuclide ventriculography at rest and exercise in subclinical hypothyroidism, and its response to L-thyroxine therapy. American Journal of Cardiology 2003 91 1327-1330.
15. Wartofsky L & Burman KD. Alterations in thyroid function in patients with systemic illness: the euthyroid sick syndrome. Endocrine Reviews 1982 3 164-217.
16. DeGroot LJ. Dangerous dogmas in medicine: the nonthyroidal illness syndrome. Journal of Clinical Endocrinology and Metabolism 1999 84 151-164.
17. DeGroot LJ. Nonthyroidal illness syndrome is functional central hypothyroidism, and if severe, hormone replacement is appropriate in light of present knowledge. Journal of Endocrinological Investigation 2003 26 1163-1170.
18. Stathatos N & Wartofsky L. The euthyroid sick syndrome: is there a physiologic rationale for thyroid hormone treatment? Journal of Endocrinological Investigation 2003 26 1174-1179.
19. Spratt DI, Frohnauer M, Cyr-Alves H, Kramer RS, Lucas FL, Morton JR, Cox DF, Becker K & Devlin JT. Physiological effects of nonthyroidal illness syndrome in patients after cardiac surgery. American Journal of Physiology-Endocrinology and Metabolism 2007 293 E310-E315.
20. Girvent M, Maestro S, Hernández R, Carajol I, Monné J, Sancho JJ, Gubern JM & Sitges-Serra A. Euthyroid sick syndrome, associated endocrine abnormalities, and outcome in elderly patients undergoing emergency operation. Surgery 1998 123 560-567.
21. Duntas LH, Nguyen TT, Keck FS, Nelson DK & DiStefano JJ III. Changes in metabolism of TRH in euthyroid sick syndrome. European Journal of Endocrinology 1999 141 337-341.
22. Beigneux AP, Moser AH, Shigenaga JK, Grunfeld C & Feingold KR. Sick euthyroid syndrome is associated with decreased TR expression and DNA binding in mouse liver. American Journal of Physiology-Endocrinology and Metabolism 2003 284 E228-E236.
23. Manowitz NR, Mayor GH, Klepper MJ & DeGroot LJ. Subclinical hypothyroidism and euthyroid sick syndrome in patients with moderate-to-severe congestive heart failure. American Journal of Therapeutics 1996 3 797-801.
24. Ascheim DD & Hryniewicz K. Thyroid hormone metabolism in patients with congestive heart failure: the low triiodothyronine state. Thyroid 2002 12 511-515.
25. Chopra IJ. Euthyroid sick syndrome: is it a misnomer? Journal of Clinical Endocrinology and Metabolism 1997 82 329-334.
26. Gangemi EN, Garino F, Berchialla P, Martinese M, Arecco F, Orlandi F & Stella M. Low triiodothyronine serum levels as a predictor of poor prognosis in burn patients. Burns 2008 34 817-824.
27. Mclver B & Gorman CA. Euthyroid sick syndrome: an overview. Thyroid 1997 7 125-132.
28. Hamilton MA, Stevenson LW, Luu M &Walden JA. Altered thyroid hormone metabolism in advanced heart failure. Journal of the American College of Cardiology 1990 16 91-95.
29. 3) state: a predictor of outcome in respiratory failure?, Results of a clinical pilot study European Journal of Endocrinology 2004 151 557-560.
30. 3 are prognostic markers in critically ill patients and are associated with postpartum tissue deiodinase activities. Journal of Clinical Endocrinology and Metabolism 2005 90 4559-4565.
31. Pantos C, Mourouzis I, Xinaris C, Kokkinos AD, Markakis K, Dimopoulos A, Panagiotou M, Saranteas T, Kostopanagiotou G & Cokkinos DV. Time-dependent changes in the expression of thyroid hormone receptor α1 in the myocardium after acute myocardial infarction: possible implications in cardiac remodeling. European Journal of Endocrinology 2007 156 415-424.
32. Pingitore A, Landi P, Taddei MC, Ripoli A, L'Abbate A & Iervasi G. Triiodothyronine levels for risk stratification of patients with chronic heart failure. American Journal of Medicine 2005 118 132-136.
33. 3 syndrome: a strong prognostic predictor of death in patients with heart disease. Circulation 2003 107 708-713.
34. Prasad A. Apical ballooning syndrome: an important differential diagnosis of acute myocardial infarction. Circulation 2007 115 e56-e59.
35. Tsuchihashi K, Ueshima K, Uchida T, Ohmura N, Kimura K, Owa M, Yoshiyama M, Miyazaki S, Haze K, Ogawa H, Honda T, Hase M, Kai R & Morii I. Transient left ventricular apical ballooning without coronary artery stenosis: a novel heart syndrome mimicking acute myocardial infarction: Angina pectoris-myocardial infarction investigations in Japan. Journal of the American College of Cardiology 2001 38 11-18.
36. Bybee KA, Kara T, Prasad A, Lerman A, Barsness GW, Wright RS & Rihal CS. Transient left ventricular apical ballooning syndrome: a mimic of ST-segment elevation myocardial infarction. Annals of Internal Medicine 2004 141 858-865.
37. Wittstein IS, Thiemann DR, Lima JA, Baughman KL, Schulman SP, Gerstenblith G, Wu KC, Rade JJ, Bivalacqua TJ & Champion HC. Neurohumoral features of myocardial stunning due to sudden emotional stress. New England Journal of Medicine 2005 352 539-548.
38. Grabowski M, Filipiak KJ, Malek LA, Piatkowski R, Scislo P, Karpinski G & Opolski G. Increased B-type natriuretic peptide levels in patients with apical ballooning syndrome. International Journal of Cardiology 2008 124 404-406.
39. Pantos C, Dritsas A, Mourouzis I, Dimopoulos A, Karatasakis G, Athanassopoulos G, Mavrogeni S, Manginas A & Cokkinos DV. Thyroid hormone is a critical determinant of myocardial performance in patients with heart failure: potential therapeutic implications. European Journal of Endocrinology 2007 157 515-520.
40. Pingitore A, Iervasi G, Barison A, Prontera C, Pratali L, Emdin M, Giannessi D & Neglia D. Early activation of an altered thyroid hormone profile in asymptomatic or mildly symptomatic idiopathic left ventricular dysfunction. Journal of Cardiac Failure 2006 12 520-526.
41. Hamilton MA, Stevenson LW, Fonarow GC, Steimle A, Goldhaber JI, Child JS, Chopra IJ, Moriguchi JD & Hage A. Safety and haemodynamic effects of intravenous triiodothyronine in advanced congestive heart failure. American Journal of Cardiology 1998 81 443-447.
42. Opasich C, Pacini F, Ambrosino N, Riccardi PG, Febo O, Ferrari R, Cobelli F & Tavazzi L. Sick euthyroid syndrome in patients with moderate-to-severe chronic heart failure. European Heart Journal 1996 17 1860-1866.
43. 3 syndrome: a randomized, placebo-controlled study. Journal of Clinical Endocrinology and Metabolism 2008 93 1351-1358.
44. Knaus WA, Zimmermann JE & Wagner DP. APACHE II: a severity of disease classification system. Critical Care Medicine 1985 13 818-829.
45. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, Reichek N, Sahn D & Schnittger I. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography, American Society of Echocardiography committee on standards, subcommittee on quantitation of two-dimensional echocardiograms. Journal of the American Society of Echocardiography 1989 2 358-367.
46. Forini F, Paolicchi A, Pizzorusso T, Ratto GM, Saviozzi M, Vanini V & Iervasi G. 3,5,3′-Triiodothyronine deprivation affects phenotype and intracellular [Ca2+]i of human cardiomyocytes in culture. Cardiovascular Research 2001 51 322-330.
47. Trivieri MG, Oudit GY, Sah R, Kerfant BG, Sun H, Gramolini AO, Pan Y, Wickenden AD, Croteau W, Morreale de Escobar G, Pekhletski R, St Germain D, Maclennan DH & Backx PH. Cardiac-specific elevations in thyroid hormone enhance contractility and prevent pressure overload-induced cardiac dysfunction. PNAS 2006 103 6043-6048.
48. Tang YD, Kuzman JA, Said S, Anderson BE, Wang X & Gerdes AM. Low thyroid function leads to cardiac atrophy with chamber dilatation, impaired myocardial blood flow, loss of arterioles, and severe systolic dysfunction. Circulation 2005 112 3122-3130.
49. Biondi B & Klein I. Hypothyroidism as a risk factor for cardiovascular disease. Endocrine 2004 24 1-14.
50. Luboshitzky R, Aviv A, Herer P & Lavie L. Risk factors for cardiovascular disease in women with subclinical hypothyroidism. Thyroid 2002 12 421-425.
51. Koseki Y, Watanabe J, Shinozaki T, Sakuma M, Komaru T, Fukuchi M, Miura M, Karibe A, Kon-No Y, Numaguchi H, Ninomiya M, Kagaya Y & Shirato K. Characteristics and 1-year prognosis of medically treated patients with chronic heart failure in Japan. Circulation Journal 2003 67 431-436.
52. Pantos C, Xinaris C, Mourouzis I, Perimenis P, Politi E, Spanou D & Cokkinos DV. Thyroid hormone receptor a1: a switch to cardiac cell 'metamorphosis'? Canadian Journal of Physiology and Pharmacology 2008 59 253-269.
53. 3. Hormone and Metabolic Research 2008 40 731-734.